The gout therapeutics market is expected to experience growth, with some reports indicating strong growth by 2034 due to the launch of new therapies. However, the specific details of the market's size, share, and growth rate are unclear, with various related markets, such as rheumatology therapeutics and antisense and RNAi therapeutics, also reporting projected growth. The overall pharmaceutical market appears to be expanding, with several therapeutic areas, including migraine drugs and antihypertensive drugs, expected to reach significant values by the mid-2030s.